Cargando…
Using experimental evolution to identify druggable targets that could inhibit the evolution of antimicrobial resistance
With multi-drug and pan-drug resistant bacteria becoming increasingly common in hospitals, antibiotic resistance has threatened to return us to a pre-antibiotic era that would completely undermine modern medicine. There is an urgent need to develop new antibiotics and strategies to combat resistance...
Autores principales: | Mehta, Heer H., Prater, Amy G., Shamoo, Yousif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788704/ https://www.ncbi.nlm.nih.gov/pubmed/28928474 http://dx.doi.org/10.1038/ja.2017.108 |
Ejemplares similares
-
Mutational Switch-Backs Can Accelerate Evolution of Francisella to a Combination of Ciprofloxacin and Doxycycline
por: Mehta, Heer H., et al.
Publicado: (2022) -
Pathogenic Nocardia: A diverse genus of emerging pathogens or just poorly recognized?
por: Mehta, Heer H., et al.
Publicado: (2020) -
Microfluidic platform for spatially segregated experimental evolution studies with E. coli
por: Seo, Seokju, et al.
Publicado: (2022) -
Evolution-strengthened knowledge graph enables predicting the targetability and druggability of genes
por: Quan, Yuan, et al.
Publicado: (2023) -
Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics
por: Cowell, Annie N., et al.
Publicado: (2018)